发明名称 FELINE CD80, FELINE CD86, FELINE CD28, AND FELINE CTLA-4 NUCLEIC ACID AND POLYPEPTIDE
摘要 <P>PROBLEM TO BE SOLVED: To provide feline CD80, feline CD86, feline CD28, feline CTLA-4 nucleic acid and a polypeptide. <P>SOLUTION: There are provided isolated and purified DNA encoding feline CD80 (B7-1) ligand, feline CD86 (B7-2) ligand, feline CD28 receptor or feline CTLA-4 (CD152) receptor, as well as vectors comprising nucleic acid encoding feline CD80, feline CD86, feline CD28 or feline CTLA-4. There are also provided host cells transformed with CD80-encoding vectors, CD86-encoding vectors, CD28-encoding vectors or CTLA-4-encoding vectors; polypeptides encoded by a nucleic acid of feline CD80, feline CD86, feline CD28 or feline CTLA-4; a vaccine comprising an effective amount of polypeptides encoded by the nucleic acid of feline CD80, feline CD86, feline CD28 or feline CTLA-4; vaccines which further comprise immunogens derived from pathogens; vaccines enhancing an immune response; and vaccines suppressing an immune response. <P>COPYRIGHT: (C)2011,JPO&INPIT
申请公布号 JP2010252804(A) 申请公布日期 2010.11.11
申请号 JP20100161913 申请日期 2010.07.16
申请人 TEXAS A & M UNIV SYSTEM;SCHERING-PLOUGH LTD 发明人 COLLISSON ELLEN W;CHOI IN-SOO;WINSLOW BARBARA J;COCHRAN MARK D
分类号 C12N15/09;A61K38/00;A61K39/00;A61K39/002;A61K39/012;A61K39/02;A61K39/118;A61K39/12;A61K39/205;A61K39/21;A61K39/245;A61K39/39;A61P31/00;A61P31/04;A61P31/12;A61P31/14;A61P31/22;A61P33/00;A61P43/00;C07K14/47;C07K14/705;C12N1/15;C12N1/19;C12N1/21;C12N5/10;C12N15/12;C12N15/63;C12P21/02;C12Q1/68 主分类号 C12N15/09
代理机构 代理人
主权项
地址